Objective:To study effect of Oxcarbazepine on serum inflammatory factors, intercellular adhesion molecule 1(ICAM-1) and immune function in epileptic.Methods: Selected 95 patients who were diagnosed as epileptic into t...Objective:To study effect of Oxcarbazepine on serum inflammatory factors, intercellular adhesion molecule 1(ICAM-1) and immune function in epileptic.Methods: Selected 95 patients who were diagnosed as epileptic into the observation group and 95 cases of healthy people as the control group;The observation group was given oral oxcarbazepine, continuous treatment for six months;Measured serum inflammatory factors (IL-2, IL-6, TNF-α) level, ICAM-1 and immune-related indexes: change of periphery T lymphocyte subgroup CD3+, CD4+, CD8+and immnuneglublin (IgG, IgA, IgM) level of the observation group before and after treatment, carried out comparative analysis through comparing with the normal control group.Results:Before treatment, compared with the control group, level of IL-2, IL-6, TNF-α, ICAM-1, CD8+, IgA and IgG in observation group were significantly higher than those in control group. CD3+, CD4+ level were significantly decreased when it compared with the control group. Level of IgM in the observation group was higher than that in the control group, but the difference between two groups was not significant. Before treatment, compared inter-class, level of IL-2, IL-6, TNF-α, ICAM-1, CD8+, IgA and IgG in the observation group were significantly lower, but all of these indexes level were still remarkable higher than the control group. It was statistical significant difference;After treatment, the level of CD3+, CD4+ in the observation group were dramatically increased, but both level were still significantly lower than the control group, the difference was statistically significant;Level of IgM after treatment compared with control group and before treatment respectively was no statistical significant difference.Conclusion: The level of inflammatory factors and ICAM-1 always were abnormal in epileptic and they were always with immune dysfunction. Oxcarbazepine was capable of effectively reducing inflammatory factor and ICAM-1 level and positively regulating immune dysfunction.展开更多
文摘Objective:To study effect of Oxcarbazepine on serum inflammatory factors, intercellular adhesion molecule 1(ICAM-1) and immune function in epileptic.Methods: Selected 95 patients who were diagnosed as epileptic into the observation group and 95 cases of healthy people as the control group;The observation group was given oral oxcarbazepine, continuous treatment for six months;Measured serum inflammatory factors (IL-2, IL-6, TNF-α) level, ICAM-1 and immune-related indexes: change of periphery T lymphocyte subgroup CD3+, CD4+, CD8+and immnuneglublin (IgG, IgA, IgM) level of the observation group before and after treatment, carried out comparative analysis through comparing with the normal control group.Results:Before treatment, compared with the control group, level of IL-2, IL-6, TNF-α, ICAM-1, CD8+, IgA and IgG in observation group were significantly higher than those in control group. CD3+, CD4+ level were significantly decreased when it compared with the control group. Level of IgM in the observation group was higher than that in the control group, but the difference between two groups was not significant. Before treatment, compared inter-class, level of IL-2, IL-6, TNF-α, ICAM-1, CD8+, IgA and IgG in the observation group were significantly lower, but all of these indexes level were still remarkable higher than the control group. It was statistical significant difference;After treatment, the level of CD3+, CD4+ in the observation group were dramatically increased, but both level were still significantly lower than the control group, the difference was statistically significant;Level of IgM after treatment compared with control group and before treatment respectively was no statistical significant difference.Conclusion: The level of inflammatory factors and ICAM-1 always were abnormal in epileptic and they were always with immune dysfunction. Oxcarbazepine was capable of effectively reducing inflammatory factor and ICAM-1 level and positively regulating immune dysfunction.
